Lee, Seung Hyeon – Trademark Portfolio

Entity Type: 01

Lee, Seung Hyeon holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include IBANARI. The owner is based in Seoul.

A-321, 212, Olympic-ro, Songpa-gu

Seoul 05553 , KR

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IBANARI
IBANARI
Registered 2022
Trademark
Serial #97369795
Registered 2022

Trademark Classifications

Lee, Seung Hyeon's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Lee, Seung Hyeon have?

Lee, Seung Hyeon has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Lee, Seung Hyeon file in?

Lee, Seung Hyeon files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Lee, Seung Hyeon's most well-known trademarks?

Lee, Seung Hyeon's registered trademark portfolio includes well-known marks such as IBANARI. These are among 2 currently registered trademarks in the portfolio.

What is Lee, Seung Hyeon's trademark registration success rate?

Lee, Seung Hyeon has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.